Argentina Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence...

Argentina Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Argentina's Pharmaceuticals and Healthcare Industry

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/f545f9/argentina_pharmace)
has announced the addition of the "Argentina Pharmaceuticals and
Healthcare Report Q3 2008" report to their offering.

This report provides independent forecasts and competitive
intelligence on Argentina's pharmaceuticals and healthcare industry.

The strength of the broader Argentine economy has been crucial in
lifting the pharmaceutical market in recent years, despite continued
price controls on medicines under President Cristina Fernandez since
she took office in December 2007. But in the first half of 2008, the
economy showed signs of overheating, with the peso weakening and
inflation surging. A damaging and ongoing strike by the nation's
farmers threatens growth, which BMI now forecasts at 6.0% in 2008,
slowing markedly to 3.9% in 2009.

As the economy slips, the structural and regulatory flaws in the
Argentine market will become even more apparent. According to INDEC,
the domestic industry increased exports by 32.7% year-on-year (y-o-y)
in 2007, with industry group COOPERLA reporting a 62% jump, as local
manufacturers took advantage of the relative weakness of the peso
versus other regional currencies. But while the domestic market grew
by 14.2% in final retail price terms in 2007 according to BMI - and by
18.8% in manufacturers prices according to INDEC - poor intellectual
property (IP) protections and the continued use of 'voluntary' price
control mechanisms by the new administration limit the ability of
multinational drugmakers to benefit from the current growth momentum.

Unsurprisingly, Argentina features as one of the nine countries on
the US Trade Representative's Priority Watch List published in April
2008, and the market continues to rank seventh out of the 10 major
pharmaceutical markets in the Americas in BMI's latest Business
Environment Rankings (BER).

Key Topics Covered:

-- Executive Summary

-- Argentina - Market Summary

-- Industry Developments

-- Industry Forecast Scenario

-- Advertising

-- Competitive Landscape

-- BMI Forecast Modelling

Companies Mentioned:

-- Pfizer

-- Roche

-- Novartis

-- GlaxoSmithKline (GSK)

-- Sanofi-Aventis

-- Merck & Co

-- Boehringer Ingelheim

-- Laboratorios Roemmers

-- Laboratorios Bago

For more information visit
http://www.researchandmarkets.com/research/f545f9/argentina_pharmace

Research and Markets
Laura Wood, Senior Manager
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com

Copyright Business Wire 2008